Compound ID | 1828
GSK3882347
Class: FimH antagonist
| Spectrum of activity: | Gram-negative |
| Details of activity: | Mannose-containing small molecule drug, that targets the adhesive protein in bacteria FimH and prevents adhesion of E. coli to the bladder epithelial cells |
| Description: | Synthetic compound |
| Institute where first reported: | GSK, Fimbrion Therapeutics |
| Year first mentioned: | 2020 |
| Highest developmental phase: | Phase 1 |
| Development status: | Active (as of 2022) |
| External links: | |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.